glp-1 and psoriatic arthritis The potential role of receptor agonists in the management of disease: a scoping review Has glp-1 helped with psoriasis

Dwyer M, Shan Q, Dortona S, Maurer R, Mitchell R, Olesen H, et al

Eligible plan types exclude Defined Standard benefit plans, which charge a standard 25% coinsurance amount for all covered drugs and do not vary cost sharing by drug type or formulary tier, although plan sponsors could indicate if they wished to convert a Defined Standard benefit plan to another basic benefit type in order to become eligible

GLP-1 fatigue is a well-documented side effect that tends to worsen during periods of dosing instability

In summary, these encouraging findings underscore the potential of GLP-1RAs as a new class of therapeutics targeting the underlying pathophysiology of PD rather than solely its symptoms

10.1056/NEJM199205143262003 16

Exenatide promotes cardiac lncRNAs HOX transcript antisense RNA (HOTAIR) in Wistar rats with liver cirrhosis